Trial Profile
Evaluating Efficacy and safety of Busulfan and Fludarabine as Allogeneic Pretransplant Conditioning Therapy in Patients with Acute Myeloid Leukemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Busulfan (Primary) ; Cyclophosphamide (Primary) ; Fludarabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 16 Dec 2015 New trial record